Author + information
- Received January 10, 2019
- Revision received January 21, 2019
- Accepted January 22, 2019
- Published online May 6, 2019.
- aDivision of Cardiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
- bLambe Institute for Translational Medicine, and Curam, National University of Ireland Galway, Galway, Ireland
- ↵∗Address for correspondence:
Prof. William Wijns, Science Foundation Ireland, the Lambe Institute for Translational Medicine, Curam and Saolta University Healthcare Group, National University of Ireland Galway, University Road, Galway, Ireland.
Standardization of the most critical clinical and angiographic endpoints enables interpretability and comparability of different device trials. Since 2006, the Academic Research Consortium (ARC) group has taken the lead in gathering major stakeholders, such as the Standardized Data Collection for Cardiovascular Trials Initiative (SCTI), the Universal Definition of Myocardial Infarction (UDMI), and the Society for Cardiovascular Angiography and Interventions (SCAI), in order to agree on common definitions. As a result, consensus does exist regarding the essential definitions and reporting process for death, myocardial infarction, stroke, bleeding, or repeat revascularization.
Prof. Wijns has received speaker fees from Biotronik, MicroPort, and Terumo; institutional research grants from MicroPort, MiCell, and Terumo; has served as a medical advisor to Rede Optimus Research; and is cofounder of Argonauts. Dr. Toth has reported that he has no relationships relevant to the contents of this paper to disclose.
- Received January 10, 2019.
- Revision received January 21, 2019.
- Accepted January 22, 2019.
This article requires a subscription or purchase to view the full text. If you are a subscriber or member, click Login or the Subscribe link (top menu above) to access this article.